Buttigliero C - Search Results

1

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives.

Mosillo C, Iacovelli R, Ciccarese C, Fantinel E, Bimbatti D, Brunelli M, Bisogno I, Kinspergher S, Buttigliero C, Tucci M, Caffo O, Tortora G. Mosillo C, et al. Among authors: buttigliero c. Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11. Cancer Treat Rev. 2018. PMID: 30121492 Review.

2

Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer.

Bertaglia V, Tucci M, Fiori C, Aroasio E, Poggio M, Buttigliero C, Grande S, Saini A, Porpiglia F, Berruti A. Bertaglia V, et al. Among authors: buttigliero c. Clin Genitourin Cancer. 2013 Sep;11(3):325-330.e1. doi: 10.1016/j.clgc.2013.01.002. Epub 2013 Mar 23. Clin Genitourin Cancer. 2013. PMID: 23531429

3

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

Caffo O, De Giorgi U, Fratino L, Alesini D, Zagonel V, Facchini G, Gasparro D, Ortega C, Tucci M, Verderame F, Campadelli E, Lo Re G, Procopio G, Sabbatini R, Donini M, Morelli F, Sartori D, Zucali P, Carrozza F, D'Angelo A, Vicario G, Massari F, Santini D, Sava T, Messina C, Fornarini G, La Torre L, Ricotta R, Aieta M, Mucciarini C, Zustovich F, Macrini S, Burgio SL, Santarossa S, D'Aniello C, Basso U, Tarasconi S, Cortesi E, Buttigliero C, Ruatta F, Veccia A, Conteduca V, Maines F, Galligioni E. Caffo O, et al. Among authors: buttigliero c. Eur Urol. 2015 Jul;68(1):147-53. doi: 10.1016/j.eururo.2014.10.014. Epub 2014 Oct 25. Eur Urol. 2015. PMID: 25457020

4

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.

Buttigliero C, Vana F, Bertaglia V, Vignani F, Fiori C, Osella G, Porpiglia F, Tucci M, Scagliotti GV, Berruti A. Buttigliero C, et al. Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15. Endocrine. 2015. PMID: 25588772 Free article.

5

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment.

Iuliani M, Pantano F, Buttigliero C, Fioramonti M, Bertaglia V, Vincenzi B, Zoccoli A, Ribelli G, Tucci M, Vignani F, Berruti A, Scagliotti GV, Tonini G, Santini D. Iuliani M, et al. Among authors: buttigliero c. Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724. Oncotarget. 2015. PMID: 25904051 Free PMC article.

6

Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer.

Buttigliero C, Tucci M, Bertaglia V, Vignani F, Bironzo P, Di Maio M, Scagliotti GV. Buttigliero C, et al. Cancer Treat Rev. 2015 Dec;41(10):884-92. doi: 10.1016/j.ctrv.2015.08.002. Epub 2015 Aug 31. Cancer Treat Rev. 2015. PMID: 26342718 Free article. Review.

7

Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.

Tucci M, Bertaglia V, Vignani F, Buttigliero C, Fiori C, Porpiglia F, Scagliotti GV, Di Maio M. Tucci M, et al. Among authors: buttigliero c. Eur Urol. 2016 Apr;69(4):563-573. doi: 10.1016/j.eururo.2015.09.013. Epub 2015 Sep 28. Eur Urol. 2016. PMID: 26422676 Free article. Review.

8

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer.

Lo Iacono M, Buttigliero C, Monica V, Bollito E, Garrou D, Cappia S, Rapa I, Vignani F, Bertaglia V, Fiori C, Papotti M, Volante M, Scagliotti GV, Porpiglia F, Tucci M. Lo Iacono M, et al. Among authors: buttigliero c. Oncotarget. 2016 Mar 22;7(12):14394-404. doi: 10.18632/oncotarget.7343. Oncotarget. 2016. PMID: 26887047 Free PMC article.

9

Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer.

Vignani F, Bertaglia V, Buttigliero C, Tucci M, Scagliotti GV, Di Maio M. Vignani F, et al. Among authors: buttigliero c. Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12. Cancer Treat Rev. 2016. PMID: 26907461 Free article. Review.

10

Androgen deprivation modulates gene expression profile along prostate cancer progression.

Volante M, Tota D, Giorcelli J, Bollito E, Napoli F, Vatrano S, Buttigliero C, Molinaro L, Gontero P, Porpiglia F, Tucci M, Papotti M, Berruti A, Rapa I. Volante M, et al. Among authors: buttigliero c. Hum Pathol. 2016 Oct;56:81-8. doi: 10.1016/j.humpath.2016.06.004. Epub 2016 Jun 21. Hum Pathol. 2016. PMID: 27342909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters